Navigation Links
ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer
Date:12/8/2009

EDINA, Minn., Dec. 8 /PRNewswire/ -- ARKRAY, Inc., a global leader of human and veterinary in vitro diagnostic instruments and reagents today announced an exclusive distribution agreement with scil animal care company for the SPOTCHEM(TM) EZ Chemistry Analyzer. Scil is a global organization focused on providing high quality veterinary diagnostic equipment.

Scil's first order of business will be to re-introduce the SPOTCHEM(TM) EZ, a small bench top chemistry analyzer, to the North American veterinary industry. Other veterinary-use products from ARKRAY will follow.

More than 8,500 SPOTCHEM(TM) EZ Chemistry Analyzers have been sold globally since 2000. The SPOTCHEM(TM) EZ is a compact, bench-top analyzer that enables easy, on-the-spot testing at veterinary clinics of various sizes. The analyzer can run a panel, a single test, or a combination so veterinarians can test the way they need to without wasting unnecessary tests. The system accepts whole blood or serum samples and has a built-in centrifuge. Results are available within 8 to 15 minutes to facilitate quick diagnosis and treatment.

"We're very excited about our new partnership and look forward to launching other veterinary-use products with scil," said Jonathan Chapman, President of ARKRAY, USA.

About ARKRAY USA

ARKRAY is a global leader of high-quality, cost-effective products that are simple, convenient, and easy-to-use, including blood glucose meters, test strips, safety lancets, as well as urine and clinical chemistry products. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. For patients, this means access to cutting-edge, reliable products without sacrificing quality, and exceptional customer service.

For more information about the SPOTCHEM EZ visit www.arkraypoc.com

About scil animal care company:

Scil animal care company is a global organization dedicated to delivering animal health professionals high quality diagnostic equipment. We understand that high quality products are not enough in today's modern veterinary laboratory. Post-acquisition in-hospital training, support and service make the critical difference to the ongoing performance of the instrument as well as its financial contribution to the veterinary practice.

SOURCE ARKRAY USA


'/>"/>
SOURCE ARKRAY USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System
2. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
3. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
4. CompuCyte Announces the Release of Four-Laser Imaging Cytometers
5. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
6. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
7. ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program
8. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
9. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
10. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
11. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):